CureVac BV (CVAC) is up 1.17% Monday In Premarket Trading

CureVac BV (CVAC) has risen Monday morning, with the stock adding 1.17% in pre-market trading to 6.91. CVAC's short-term technical score of 26 indicates that the stock has traded less bullishly over the last month than 74% of stocks on the market. In the Biotechnology industry, which ranks 139 out of 146 industries, the stock ranks higher than 48% of stocks. CureVac BV has fallen 24.86% over the past month, closing at $8.94 on September 4. During this period of time, the stock fell as low as $6.50 and as high as $9.04. CVAC has an average analyst recommendation of Strong Buy. The company has an average price target of $16.25.

CVAC has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on CVAC!

See Full CVAC Report

CureVac BV has a Long-Term Technical rank of 27. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 73% of the market scoring higher. In the Biotechnology industry which is number 136 by this metric, CVAC ranks better than 136% of stocks.

Important Dates for Investors in CVAC:

-CureVac BV is set to release earnings on 2023-11-16. Over the last 12 months, the company has reported EPS of $-1.32. -We do not have a set dividend date for CureVac BV at this time. Click Here To Get The Full Report on CureVac BV (CVAC)